Ligation of the common bile duct (BDL) in the male rabbit resulted in increased gall-bladder microsomal total cyclooxygenase activity with prostaglandin E2 (PGE2) and 6-oxoprostaglandin F1, [6-oxo-PGF,., stable metabolite of prostaglandin 12 (PGI2; prostacyclin)] as the major prostanoids synthesized after 24 and 72 h. Kinetic analysis of gallbladder microsomal membrane fractions incubated with increasing levels of ['4C]arachidonic acid indicated that BDL for 24 and 72 h did not change substrate affinity (apparent Km) but markedly increased the rate of conversion (apparent Vmax ) suggesting the presence of more total enzyme responsible for synthesis of 6-oxo-PGF1. and PGE2. BDL for 24 and 72 h significantly increased gall-bladder tissue slice basal release of 6-oxo-PGF1., but not PGE2, when compared with the controls. Gall-bladder slice release of PGE2 was 3-fold less than 6-oxo-PGF1. in the control gall-bladder slices.
INTRODUCTION
The normal rabbit gall-bladder synthesizes modest amounts of endogenous prostanoids. Several authors have hypothesized that acute inflammation of the gall-bladder stimulates increased gallbladder prostanoid synthesis, which mediates biliary colic and mucosal injury [1] . We recently described a model of commonbile-duct ligation (BDL) in the rabbit as a new model of early acute gall-bladder inflammation. BDL for 1-3 days in the male rabbit produced both progressive histological changes of acute cholecystitis and exaggerated gall-bladder microsomal prostanoid synthesis compared with sham-operated controls [2] [3] [4] [5] [6] [7] . Gall-bladder microsomal membrane fractions prepared from rabbits treated with BDL for 6, 24 and 72 h exhibited a marked increase in total cyclo-oxygenase activity, with prostaglandins 12 (prostacyclin) and E2 (PGI2 and PGE2) as the major prostanoids synthesized [3] [4] [5] [6] [7] . Although not specifically addressed, the increased gall-bladder microsomal cyclooxygenase activity after BDL could have been the result of new enzyme formation, increased enzyme efficiency or a combination of both. The presence of increased endogenous gall-bladder PGI2 synthesis could have a profound influence on altering normal fluid absorption and contraction and thus contribute to gallbladder distension and mucosal injury described during evolving acute cholecystitis [8] [9] [10] [11] [12] [13] .
The studies described above utilized gall-bladder microsomal membrane fractions incubated with '4C-labelled arachidonic acid to examine prostanoid synthesis in the BDL model. These experiments provided insight into the effects of evolving cholecystitis on gall-bladder microsomal prostanoid synthesis, but not on whole gall-bladder tissue prostanoid synthesis and release.
The mechanism underlying exaggerated gall-bladder microsomal synthesis of PGI2 and PGE2 described after rabbit BDL is the primary focus of the present study. The methodologies utilized to investigate this question will include the kinetic analysis described by Eisenthal & Cornish-Bowden and Merino [14, 15] and the method of protein blot analysis [16] [17] [18] . A secondary focus of the present paper is to utilize intact gall-bladder tissue slices to determine if BDL in the rabbit stimulates both increased prostanoid synthesis and release. MATERIALS 
Experimental animal model
IThe BDL model has been previously described [2] [3] [4] [5] [6] [7] . Male New Zealand White rabbits (2-3 kg) were anaesthetized with ketamine (50 mg/kg) and xyalazine (10 mg/kg) and maintained on halothane. The abdomen was shaved and washed with soap followed by alcohol and betadine. A midline laparotomy was performed and the common bile duct was identified just before entry into the duodenum and ligated with 4-0 silk suture (BDL) or served as a sham-operated control (BDL-sham). The gallbladder was harvested from control rabbits and compared with those removed from animals after BDL for 24 and 72 h.
Abbreviations used: PG, prostaglandin; BDL, (common-)bile-duct ligation; PBS, phosphate-buffered saline; r.i.a., radioimmunoassay. § To whom correspondence should be addressed.
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Harvested gall-bladder from BDL and control groups were either prepared as whole-tissue slices or microsomal membrane fractions (see below).
Gail-bladder slice preparations
Gall-bladder tissue slices were utilized to examine the synthesis and release of prostanoids from control and BDL groups. The control and BDL groups were prepared under sterile operative conditions as previously described [2] [3] [4] [5] [6] [7] . Gall-bladders were then removed from control and BDL groups, cut into slides and placed in oxygenated Krebs-Henseleit buffer, pH 7.4, at 37°C to measure basal slice release of 6-oxo-PGF1a, a stable metabolite of PGI2, and PGE2. The gall-bladder slice was removed after 60 min, and the bath solution was immediately frozen at -20°C and stored until analysed for prostanoids by radioimmunoassay (r.i.a.). The tissue slices were weighed, then homogenized in 0.1 M-potassium phosphate buffer/0.01% Triton with a UltraTurrax homogenizer (Tekmar, Cincinnati, OH, U.S.A.) for 150 s. The homogenate was clarified by centrifugation (8000 g, 10 min) and the supernatant decanted and analysed for protein content by the method of Bradford [18a] .
R.i.a. of arachidonic acid metabolites
Our methodology for radioimmunassay of 6-oxo-PGF1, and PGE2 has been described previously [19] . In brief, 6-oxo-PGF1. and PGE2 were measured from the unextracted bath solution by r.i.a. All samples and standards were measured in duplicate.
Antisera were obtained in freeze-dried form from Dr. Lawrence Levine, Department of Biochemistry, Brandeis University (anti-6-oxo-PGF1, serum) and Advanced Magnetics, Cambridge, MA (anti-PGE2 serum). Dilutions in assay buffer of 1:5000 and 1: 8000 (v/v) for PGE2 and 6-oxo-PGFia respectively were used to obtain 40-600% binding of a zero standard 'blank'. Crossreactivity of antisera from Dr. L. Levine has been published, and for 6-oxo-PGFia was < I% to PGF2a, PGD2, thromboxane B2 and 13,14-dihydro-PGE2 [20] . Cross-reactivity of the PGE2 antiserum was given by Advanced Magnetics as 500% to PGE1 and < 1% 6-oxo-PGF1,.
The standard curve was constructed using the smoothed-spline function (r.i.a. computer software package SecuRIA; Packard Instruments, Downers Grove, IL, U.S.A.). Unbound, unabsorbed tracer (referred to as 'non-specific binding') was quantified in tubes containing only labelled ligand and dextrancoated charcoal. Inter-assay and intra-assay variation was 7-9 % for 6-oxo-PGF1. and 14-15 % for PGE. Sensitivity (the amount of unlabelled standard causing 5 % decrease from maximal binding of the blank) was approx. 30 pg/ml. Data are expressed as ng/mg of protein (mean+ S.E.M.).
Preparation of microsomal membrane fractions
The method of preparation ofmicrosomal membrane fractions has been described for several different tissues (our laboratory and others), including kidney, arteries, brain, gastrointestinal tract and gall-bladder [6, [21] [22] [23] [24] [25] [26] [27] . Harvested gall-bladders from control and BDL groups were weighed and added to 3 vol. (w/v) of oxygenated 100 mM-potassium phosphate buffer with 10 mM-EDTA (to chelate Ca2 , thus inhibiting any Ca2+-dependent tissue phospholipases) and 1 % fatty-acid-poor bovine BSA (Calbiochem; to absorb any released arachidonic acid), pH 7.4, at 40C [22, 23] . The tissue was minced, and the resulting suspension was homogenized on ice with a Polytron instrument and spun down at 8000 g for 15 min in a Sorvall centrifuge at 4 'C. The supernatant was removed and centrifuged for 65 min at 105000g in a refrigerated Beckman L7-55 ultracentrifuge. The surface of the microsomal pellet was carefully washed with 100 mM-potassium phosphate buffer, pH 7.4. The pellet was resuspended in 100 mM-potassium phosphate buffer, pH 7.4, at 4°C and adjusted to obtain a protein concentration of 0.1 mg/ 100,l aliquot to be used in the assay. The reactions took place in silicone-treated (Prosil-28; Baxter Scientific Products, McGaw Park, IL, U.S.A.) 12 mm x 75 mm tubes. Each tube received 100,1 of the microsomal suspension contai-ning 0.1 mg of protein [18a]. The microsomal suspension was incubated with increasing levels of [14C]arachidonic acid (3 nM-3/zM) in the presence of 1.2 mM-L-adrenaline and 1 mM-GSH at 37°C for 2 min. Our preliminary experiments identified 750 ng of the labelled [14C]arachidonic acid to be in excess and not to limit prostanoid synthesis. The 2 min period of incubation was derived from preliminary time-course studies which demonstrated linear prostanoid synthesis up to 20 min of incubation using 0.75 ,tg of the labelled substrate. When inhibitors were used, 5 mmimidazole (an inhibitor of thromboxane synthetase) or 10 ftMindomethacin (a cyclo-oxygenase inhibitor) were added to the microsomes [26, 27] . Indomethacin, added to the 'in vitro' reaction mixture as a control, decreased total prostanoid release in all normal and BDL groups [29] . Imidazole decreased thromboxane B2 synthesis in these groups as well [30] . The reaction was terminated by acidification to pH 3.0 with 4 M-formic .acid. The reaction mixture was extracted twice with 2 vol. of ethyl acetate. The supernatant was collected, dried under nitrogen and reconstituted with chloroform/methanol (2: 1, v/v). The microsomal extracts were subjected to t.l.c. in solvent system A9, the organic phase of ethyl acetate/2,2,4-trimethylpentaneacetic acid/ water (10:5:2:10, by vol.) [31] . Authentic unlabelled prostanoid standards were added to the thin-layer plates and identified by the use of 12 vapour. The radioactive zones corresponding to the prostanoid standards were located, and their radioactivities were counted in liquid-scintillation cocktail (Aquassure; du Pont-NEN, Doraville, GA, U.S.A.) with a LKB 1217 liquid-scintillation counter. Data were calculated as ng (of total or individual PG) per min per mg of protein (mean + S.E.M.; n = 6 all groups). The substrate levels utilized were plotted against the rate of product formation by the method described by Eisenthal & Cornish-Bowden [14] and Merino [15] [15] . The values are the means, with the standard errors ranging from 10 to 30% (n = 6). Synthesis rates of the other primary prostanoids (PGF2a, PGD2 and PGA2) are presented in Table 3 . Unlike the data for 6-oxo-PGFix and PGE2, synthesis of the other primary prostanoids decreased after 3 days of BDL and showed an increased Km for PGD2 and PGA2 after 3 days of BDL (Table 3) . Synthesis of thromboxane B2 in the control and BDL groups was minimal and is not shown in Table 3 .
Gall-bladder slice PG synthesis and release
Gall-bladder slice basal synthesis and release of 6-oxo-PGFla and PGE2 are presented in Table 4 . Control gall-bladder slice Gall-bladder-slice basal release of thromboxane B2 (a metabolite of thromboxane A2) was 3-fold less than PGE2 or 6-oxoPGFla release in the control and experimental groups. There were no significant differences in gall-bladder-slice release of thromboxane B2 between the control and experimental groups.
Immunoblot analysis
Since BDL increased both the synthesis rate and release of 6-oxo-PGFxa and PGE2, total microsomal membrane protein fractions were prepared from control and BDL gall-bladders and analysed by immunoblot analysis with antibodies against prostacyclin synthase (Fig. 3) . The total protein profiles of the microsomal membrane fractions were not significantly different in control and 3DBDL animals (Fig. 3a) . However, BDL increased the gall-bladder microsomal content of prostacyclin synthase (Fig. 3b) This represents a significant 5-fold increase (P < 0.002) in prostacyclin synthase content in the gall-bladder microsomes obtained from the 72 h-BDL group compared with the control (Fig. 3b) . Arrows denote the position of the immunoreactive protein. Peak areas were determined by using an LKB 2222-020 UltraScan XL laser densitometer. Means+ S.E.M. were calculated. A significant (P < 0.002; Student's two-tailed t test) increase in specific prostacyclin synthase content was observed in the 72 h-BDL animals. DISCUSSION BDL in the rabbit was described recently as a new animal model of acute cholecystitis [2] [3] [4] [5] [6] [7] . BDL for 6, 24 and 72 h induced both gall-bladder microsomal cyclo-oxygenase activity and histological changes identical with that observed in human early acute cholecystitis [6] . The major gall-bladder microsomal prostanoids synthesized after all time periods of BDL were PGI2 and PGE2. Previously we showed that PGI2 inhibits gall-bladder water transport in vitro in a dose responsive manner. Thus elevated levels of PGI2 in the gall-bladder likely play a central role in the biochemical and physiological changes associated with acute gall-bladder inflammation [8] . Two other laboratories reported similar findings in two different animal models of acute cholecystitis [35, 36] . The present study, however, provides a possible mechanism for the increased gall-bladder microsomal synthesis of prostacyclin after BDL.
Two different biochemical measures were utilized to determine the mechanism of increased gall-bladder microsomal prostanoid synthesis after BDL. A kinetic enzyme analysis [14] [15] and the technique of protein blot analysis [16] [17] [18] were used to define the specific arachidonic acid metabolic pathway that leads to increased prostaglandin content in the inflamed gall-bladder [14, 15] . BDL stimulated a quantitative change in the enzymes involved with gall-bladder conversion of arachidonic acid into 6- Since quantitative changes in the synthesis rates of -specific arachidonic acid metabolites were observed, the specific content of the enzymes responsible for the synthesis of 6-oxo-PGF1. and PGE2 were measured by protein blot and immunoreaction with antibodies against cyclo-oxygenase and prostacyclin synthase. The total protein profiles of the control and inflamed gallbladder microsomes were unchanged by inflammation. Acute inflammation induced only a slight increase in cyclo-oxygenase content (results not shown), but a 5-fold increase in prostacyclin synthase content was measured in the microsomes from 72 h-BDL as compared with controls. The data from these two independent methods are consistent with the presence of more total enzymes responsible for 6-oxo-PGF1, and PGE2 synthesis rather than a change in enzyme affinity or the appearance of a novel enzyme.
BDL for 72 h increased the Vmax. for total PG synthesis by 41 % and increased the Vmax for 6-oxo-PGF1a and PGE2 by 3- fold. This discrepancy was explained by the decreased Vmax values for PGF2a5 PGD2 and PGA2 and the increased Km or change in affinity of the specific enzymes responsible for conversion of PGH2 into PGD2 and PGA2. These data support our previous study, which examined sex differences during evolving gall-bladder inflammation. Total PG synthesis was 4-fold higher in the control female rabbit gall-bladder microsomes than the male. BDL for 3 days only moderately increased total PG synthesis in the female rabbit gall-bladder, dramatically increased gall-bladder synthesis of 6-oxo-PGF1a and decreased synthesis of all other primary prostanoids. Unlike the female rabbit gallbladder, the male rabbit gall-bladder significantly increased total Vol. 288 589 . .:
:.:j oxo-PGF1. [37] .
Previous studies examining the effects of pathological stimuli on whole-organ or cellular cyclo-oxygenase activity have shown similar results [22] [23] [24] [38] [39] [40] [41] [42] [43] . Several of these studies demonstrated that increased prostanoid synthesis after pathological stimuli was due to new protein and RNA synthesis [22, 39] . The present data also suggested that a similar mechanism involving new protein synthesis increases the total gall-bladder cyclo-oxygenase activity after BDL.
A comparison of control and BDL gall-bladder-slice basal PGI2 and PGE2 synthesis and release is presented in Table 4 . Control gall-bladder release of PGI2 was 3-fold higher than that of PGE2. BDL for 24 and 72 h significantly increased gallbladder basal 6-oxo-PGFla release, but not that of PGE2, when compared with the control. BDL-stimulated 6-oxo-PGFlarelease was 3-and 5-fold higher than BDL-stimulated PGE2 release after 24 and 72 h of BDL respectively. Similar to the situation with BDL groups, control gall-bladder-slide 6-oxo-PGF.a release was 3-fld higher than control gall-bladder-slice PGE2 release. Although BDL similardy stimulated the rate of gall-bladder microsomal substrate conversion (Vmax ) into both PGE2 and 6-oxo-PGFla, whole-gall-bladder tissue showed a preferential release for 6-oxo-PGF1L over PGE2 release.
Prostanoids are paracrine substances that are produced by the entire gastrointestinal tract, including the gall-bladder [6, 21, 25] . Previous studies in vitro have shown that PGI2 decreased gallbladder normal fluid absorption when applied exogenously to rabbit gall-bladder [8] . We hypothesized that increased gallbladder PGI2 synthesis is an important factor contributing to gall-bladder distension and mucosal disruption, two important stages in the early onset of acute cholecystitis. Our findings of increased synthesis and release of gall-bladder PGI2 after rabbit BDL support this hypothesis. BDL in the rabbit stimulated increased preferential endogenous PGI2 synthesis and release, as indicated by our microsomal kinetic and tissue-slice experiments. A possible model is presented in which the net result of increased gall-bladder PGI2 is decreased fluid absorption, causing increased gall-bladder distension, subsequent mucosal injury and the onset of clinical acute cholecystitis.
